| Vagina |
0 |
0.58 |
| Obesity |
0 |
0.48 |
| Vaginal Hemorrhage |
0 |
0.45 |
| Social Determinants of Health |
0 |
0.4 |
| Estrogen |
0 |
0.31 |
| Transdermal |
0 |
0.27 |
| Health Care Quality, Access, and Evaluation |
0 |
0.23 |
| Hemorrhage |
0 |
0.19 |
| Thromboembolism |
0 |
0.19 |
| Food and Drug Administration (FDA) |
0 |
0.18 |
| Revenue and Practice Management |
0 |
0.15 |
| Sexually Transmitted Infection |
0 |
0.15 |
| Patient Safety |
0 |
0.12 |
| Pulmonary Embolism |
0 |
0.12 |
| Wound Management |
0 |
0.11 |
| Deep Venous Thrombosis |
0 |
0.09 |
| Headache |
0 |
0.09 |
| Medical Life |
0 |
0.09 |
| Adherence |
0 |
0.08 |
| Adverse Effects |
0 |
0.08 |
| Anticoagulation Therapy |
0 |
0.08 |
| Burnout |
0 |
0.08 |
| Burns |
0 |
0.08 |
| Chlamydial Infection |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Europe |
0 |
0.08 |
| Gonorrhea |
0 |
0.08 |
| Metrorrhagia |
0 |
0.08 |
| Nausea |
0 |
0.08 |
| Pruritus |
0 |
0.08 |
| Salary and Compensation |
0 |
0.08 |
| Surfactant |
0 |
0.08 |
| Thrombosis |
0 |
0.08 |
| Lipids Management |
0 |
0.07 |
| Adhesion |
0 |
0.04 |
| Canada |
0 |
0.04 |
| Cystitis |
0 |
0.04 |
| Embolism |
0 |
0.04 |
| Face |
0 |
0.04 |
| Health Care Facilities, Manpower, and Services |
0 |
0.04 |
| Hormonal Contraception |
0 |
0.04 |
| Liver |
0 |
0.04 |
| Menorrhagia |
0 |
0.04 |
| Metabolism |
0 |
0.04 |
| Pain |
0 |
0.04 |
| Pain Management |
0 |
0.04 |
| Pharmacokinetics |
0 |
0.04 |
| Plasma |
0 |
0.04 |
| Socioeconomics |
0 |
0.04 |
| Travel Medicine |
0 |
0.04 |
| Triglycerides |
0 |
0.04 |
| Urinary Tract Infection |
0 |
0.04 |
| Vein |
0 |
0.04 |
| Weight Gain |
0 |
0.04 |
| Weight Management |
0 |
0.04 |